Clinical response of vedolizumab at week 6 predicted endoscopic remission at week 24 in ulcerative colitis.

Daisuke SaitoMinoru MatsuuraRyo OzakiSotaro TokunagaShintaro MinowaTatsuya MitsuiMiki MiuraAkihito SakurabaMari HayashidaJun MiyoshiTadakazu Hisamatsu

Published in: JGH open : an open access journal of gastroenterology and hepatology (2021)

In vedolizumab treatment for ulcerative colitis, the clinical response at week 6 can be a predictor for endoscopic remission at week 24.

Keyphrases

ulcerative colitis
ultrasound guided
placebo controlled
randomized controlled trial
clinical trial
rheumatoid arthritis
systemic lupus erythematosus
endoscopic submucosal dissection